0001209191-21-038769.txt : 20210607
0001209191-21-038769.hdr.sgml : 20210607
20210607200019
ACCESSION NUMBER: 0001209191-21-038769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210603
FILED AS OF DATE: 20210607
DATE AS OF CHANGE: 20210607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tomasi Adam
CENTRAL INDEX KEY: 0001637219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38582
FILM NUMBER: 211000931
MAIL ADDRESS:
STREET 1: ZS PHARMA, INC.
STREET 2: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allakos Inc.
CENTRAL INDEX KEY: 0001564824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454798831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 975 ISLAND DRIVE
STREET 2: SUITE 201
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-597-5002
MAIL ADDRESS:
STREET 1: 975 ISLAND DRIVE
STREET 2: SUITE 201
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-03
0
0001564824
Allakos Inc.
ALLK
0001637219
Tomasi Adam
975 ISLAND DRIVE, SUITE 201
REDWOOD CITY
CA
94065
0
1
0
0
President and COO
Common Stock
2021-06-07
4
S
0
2487
92.03
D
148220
D
Common Stock
2021-06-04
4
S
0
642
90.26
D
150707
D
Common Stock
2021-06-03
4
F
0
1777
92.20
D
151349
D
Common Stock
3953
I
See footnote
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.17 to $92.66 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
Includes shares of common stock purchased under the Company's 2018 Employee Stock Purchase Plan.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.10 to $90.39 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
Shares withheld to satisfy the tax obligations by the reporting person in connection with the vesting of RSUs.
Includes 3,953 shares received as a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners Management VIII, LLC (APM VIII), without consideration, to the reporting person as a non-managing member of APM VIII.
The shares are held by Mr. Tomasi and Carrie Tomasi, as Trustees of the Tomasi Living Trust dated July 14, 2017.
/s/ Adam Tomasi
2021-06-07